You are here

Home » Content

Hızlı İlerleyen Glomerülonefrit Tanısı Konulan Olguların Retrospektif Analizi

Retrospective Analysis of the Cases Diagnosed With Rapidly Progressive Glomerulonephitis

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Aim: In the present study, we investigated clinical and histopathological findings, treatment, and course of patients with crescentic glomerulonephritis in our center. Patients and Methods: 35 patients who were diagnosed with crescentic glomerulonephri-tis by renal biopsy were retrospectively investigated. Results: 25 (71.4%) of the patients were male and mean age was 34.43 ± 15.7 years. All of 13 patients had serum creatinine level > 5 mg/dl and 7 of 18 patients who had serum creatinine level < 5 mg/dl did not respond to treatment and developed end stage renal disease (ESRD). The cres-centic glomerular change percentage was significantly higher in patients who did not respond to treatment and developed ESRD than those who respond to treatment (79.04 ± 21.57 vs. 52.21 ± 20.63, p = 0.002). There was a significant positive correlation between the cres-centic glomerular change percentage and serum creatinine level. Conclusion: In crescentic glomerulonephritis, there is a significant correlation between histopathological findings and renal function. In patients who have severe renal failure (serum creatinine level >5 mg/dl) at diagnosis, prognosis of crescentic glomerulonephritis is poor and the development of ESRD is common, although treatment is given.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç:Bu çalışmada merkezimizde takip edilen kresentik glome-rülonefritli hastaların klinik ve histopatolojik bulgularını, tedavilerini ve seyirlerini inceledik. Hastalar ve Yöntem: Böbrek biyopsisi yapılmak suretiyle kresentik glomerülonefrit tanısı konulan 35 hasta retrospektif olarak incelendi. Bulgular: Hastaların 25'i (%71.4) erkekti ve ortalama yaş 34.43 ± 15.7 idi. Serum kreatinin düzeyi 5 mg/dl veya daha yüksek olan 13 hastanın hiçbiri tedaviye yanıt vermedi ve son dönem böbrek yetmezliği (SDBY) gelişti. Serum kreatinin düzeyi 5 mg/dl'nin altında olan 18 hastanın ise yedisinde SDBY gelişti. Histopatolojik incelemede kresent görünümü yüzdesi SDBY gelişen hastalarda, gelişmeyenlerden anlamlı olarak yüksekti (sırasıyla 79.04 ± 21.57'ye karşı 52.21 ± 20.63, p = 0.002). Kresent görünümü yüzdesi ile serum kreatinin düzeyleri arasında belirgin pozitif korelasyon saptandı. Sonuç: Kresentik glomerülonefritte histolojik bulgularla böbrek fonksiyonları arasında belirgin bir ilişki vardır. Tanı anında ciddi böb¬rek yetmezliği (serum kreatinin düzeyi 5 mg/dl veya daha yüksek) olan hastalarda, kresentik glomerülonefrit tedaviye rağmen kötü gidişlidir.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_17_pp_10-15.pdf
  • 1
10-15
  • Turkish

REFERENCES

References: 

1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988;11:449-464.
2. McLeish KR, Yum MN, Luft FC. Rapidly progressive glomerulonephritis in adults: clinical and histologic correlations. Clin Nephrol 1978;10:43-50.
3. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003;63:1164-1177.
4. Gupta RK. Pauci-immune crescentic glomerulonephritis. Indian J Pathol Microbiol 2003;46:357-366.
5. Savage CO. ANCA-associated renal vasculitis. Kidney Int
2001;60:1614-1627.
6. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-1523.
7. Franssen CF, Stegeman CA, Kallenberg CG, et al. Antiprote-inase 3- and antimyeloperoxidase-associated vasculitis. Kid¬ney Int 2000;57:2195-2206.
8. Langford CA, Balow JE. New insights into the immunopatho-genesis and treatment of small vessel vasculitis of the kidney. Curr Opin Nephrol Hypertens 2003;12:267-272.
9. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001;13:48-55.
10. Wiggins RC, Kershaw DB. Crescentic glomerulonephritis. In: Massry SG, Glassock RJ (eds), Textbook of Nephrology. Lip-pincott Williams & Wilkins, Philadelphia 2001, pp 720-725.
11. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ.
Prognostic markers in patients with antineutrophil cytoplas-mic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.
12. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033-1042.

Thank you for copying data from http://www.arastirmax.com